George Washington University Hospital
Washington D.C., District of Columbia, 20037, United States
NCT Number: NCT02882256
Patients seen in the ED with either a laceration, minor head injury, or urinary tract infection will be randomized to one of two groups. Both groups will receive the standard written discharge instructions; in addition, one group will watch video discharge instructions. Each patient will be asked to complete a short survey with questions related to the discharge instructions received in the ED, and will be called 5-7 days after the ED visit to ask questions about discharge instructions and the ED visit.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Washington D.C., District of Columbia, 20037, United States
Patients will be enrolled in the study at George Washington University Hospital's Emergency Department. Patients who consent will be randomly assigned to one of two groups; (1) standard Written Discharge Instructions from the nursing staff (2) standard Written Discharge Instructions from the nursing staff AND watching the Video Discharge Instructions on a tablet. Subjects will complete a survey after they have received their discharge instructions and before leaving the ER. Several (5-7) days after leaving the Emergency Department, subjects will receive a phone call from one of the investigators staff members asking 2-3 questions about their ED visit and how they treated the condition at home. The survey questions at discharge and at follow-up will pertain to how to care for the condition and will be based on the discharge instructions. The study is designed to determine if patients retain health information more accurately if they watch a video in addition to being given written information. A total sample size of 200 participants will be recruited. Enrollment for this study will begin June of 2016 and will continue until the investigators have enough participants. The data analyst will be blinded to treatment assignment when analyzing the data.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Discharge instructions provided in video form
Time frame: Immediately before leaving the emergency department for discharge home.
Right after the provider who discharges the patient goes over the discharge instructions with the subject, the investigators will administer the discharge questionnaire.
Time frame: Five to seven days after the index ED visit.
Subjects will complete a telephone follow-up interview 5-7 days after ED discharge.
Time frame: Five to seven days after the index ED visit.
Subjects will complete a telephone follow-up interview 5-7 days after ED discharge.
Time frame: Five to seven days after the index ED visit.
Subjects will complete a telephone follow-up interview 5-7 days after ED discharge.
Time frame: Five to seven days after the index ED visit.
Subjects will complete a telephone follow-up interview 5-7 days after ED discharge.
George Washington University
Other
Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions for 3 Common Chief Complaints in the Emergency Department (ED)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00457600
Asthma, Bronchial Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06059846
Acute Pyelonephritis, Female Urogenital Diseases
Miami, Florida, United States
View Trial DetailsNCT01388413
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Garches, France
View Trial DetailsNCT05880602
Disease Attributes, Female Urogenital Diseases
Taichung, Taiwan
View Trial Details